Literature DB >> 25692455

Parents' decision-making about the human papillomavirus vaccine for their daughters: I. Quantitative results.

Andrea Krawczyk1, Bärbel Knäuper, Vladimir Gilca, Eve Dubé, Samara Perez, Keven Joyal-Desmarais, Zeev Rosberger.   

Abstract

Vaccination against the human papillomavirus (HPV) is an effective primary prevention measure for HPV-related diseases. For children and young adolescents, the uptake of the vaccine is contingent on parental consent. This study sought to identify key differences between parents who obtain (acceptors) and parents who refuse (non-acceptors) the HPV vaccine for their daughters. In the context of a free, universal, school-based HPV vaccination program in Québec, 774 parents of 9-10 year-old girls completed and returned a questionnaire by mail. The questionnaire was based on the theoretical constructs of the Health Belief Model (HBM), along with constructs from other theoretical frameworks. Of the 774 parents, 88.2% reported their daughter having received the HPV vaccine. Perceived susceptibility of daughters to HPV infection, perceived benefits of the vaccine, perceived barriers (including safety of the vaccine), and cues to action significantly distinguished between parents whose daughters had received the HPV vaccine and those whose daughters had not. Other significant factors associated with daughter vaccine uptake were parents' general vaccination attitudes, anticipated regret, adherence to other routinely recommended vaccines, social norms, and positive media influence. The results of this study identify a number of important correlates related to parents' decisions to accept or refuse the HPV vaccine uptake for their daughters. Future work may benefit from targeting such factors and incorporating other health behavior theories in the design of effective HPV vaccine uptake interventions.

Entities:  

Keywords:  CAIQ, Commission d’Accès à l’Information du Québec; CI, Confidence Interval; GW, Genital Warts; HBM, Health Belief Model; HL, Hosmer-Lemeshow; HPV, Human Papillomavirus; Human papillomavirus; OR, Odds Ratio; RAMQ, Régie de l’Assurance Maladie du Québec; STI, Sexually Transmitted Infection; US, United States; cancer vaccine; decision-making; papillomavirus vaccine; quantitative research; social determinants of health; vaccine attitudes

Mesh:

Substances:

Year:  2015        PMID: 25692455      PMCID: PMC4514251          DOI: 10.1080/21645515.2014.1004030

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  55 in total

1.  Provinces weighing HPV vaccination of boys.

Authors:  Laura Eggertson
Journal:  CMAJ       Date:  2012-02-27       Impact factor: 8.262

Review 2.  "HPV? Never heard of it!": a systematic review of girls' and parents' information needs, views and preferences about human papillomavirus vaccination.

Authors:  Maggie Hendry; Ruth Lewis; Alison Clements; Sarah Damery; Clare Wilkinson
Journal:  Vaccine       Date:  2013-09-09       Impact factor: 3.641

3.  The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil.

Authors:  Richard M Haupt; Heather L Sings
Journal:  J Adolesc Health       Date:  2011-09-09       Impact factor: 5.012

4.  Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink.

Authors:  Julianne Gee; Allison Naleway; Irene Shui; James Baggs; Ruihua Yin; Rong Li; Martin Kulldorff; Edwin Lewis; Bruce Fireman; Matthew F Daley; Nicola P Klein; Eric S Weintraub
Journal:  Vaccine       Date:  2011-09-09       Impact factor: 3.641

Review 5.  A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability.

Authors:  Jennifer D Allen; Gloria D Coronado; Rebecca S Williams; Beth Glenn; Cam Escoffery; Maria Fernandez; Raegan A Tuff; Katherine M Wilson; Patricia Dolan Mullen
Journal:  Vaccine       Date:  2010-04-20       Impact factor: 3.641

Review 6.  What works in prevention. Principles of effective prevention programs.

Authors:  Maury Nation; Cindy Crusto; Abraham Wandersman; Karol L Kumpfer; Diana Seybolt; Erin Morrissey-Kane; Katrina Davino
Journal:  Am Psychol       Date:  2003 Jun-Jul

7.  Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV.

Authors:  Amanda F Dempsey; Gregory D Zimet; Robert L Davis; Laura Koutsky
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

8.  HPV vaccine acceptability in a rural Southern area.

Authors:  Karah I Fazekas; Noel T Brewer; Jennifer S Smith
Journal:  J Womens Health (Larchmt)       Date:  2008-05       Impact factor: 2.681

9.  Disparities in how parents are learning about the human papillomavirus vaccine.

Authors:  Jessica Hughes; Joan R Cates; Nicole Liddon; Jennifer S Smith; Sami L Gottlieb; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

10.  Trust versus concerns-how parents reason when they accept HPV vaccination for their young daughter.

Authors:  Maria Gottvall; Maria Grandahl; Anna T Höglund; Margareta Larsson; Christina Stenhammar; Bengt Andrae; Tanja Tydén
Journal:  Ups J Med Sci       Date:  2013-06-19       Impact factor: 2.384

View more
  23 in total

1.  Parents' decision-making about the human papillomavirus vaccine for their daughters: II. Qualitative results.

Authors:  Andrea Krawczyk; Samara Perez; Leonora King; Maryline Vivion; Eve Dubé; Zeev Rosberger
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Environmental factors affecting mothers' decision-making about the HPV vaccination for their daughters.

Authors:  Gyumin Han; Hyunmi Son
Journal:  Hum Vaccin Immunother       Date:  2021-08-17       Impact factor: 4.526

3.  Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine.

Authors:  Eric Adjei Boakye; Betelihem B Tobo; Rebecca P Rojek; Kahee A Mohammed; Christian J Geneus; Nosayaba Osazuwa-Peters
Journal:  Hum Vaccin Immunother       Date:  2017-08-30       Impact factor: 3.452

4.  Human Papillomavirus Awareness in Haiti: Preparing for a National HPV Vaccination Program.

Authors:  Margaret W Gichane; William A Calo; Schatzi H McCarthy; Kathy A Walmer; Joel C Boggan; Noel T Brewer
Journal:  J Pediatr Adolesc Gynecol       Date:  2016-08-04       Impact factor: 1.814

5.  The association between maternal human papillomavirus (HPV) experiences and HPV vaccination of their children.

Authors:  Erika Biederman; Kelly Donahue; Lynne Sturm; Victoria Champion; Gregory Zimet
Journal:  Hum Vaccin Immunother       Date:  2020-10-07       Impact factor: 3.452

Review 6.  Human papilloma virus (HPV) vaccination: Questions and answers.

Authors:  Allison Mejilla; Emily Li; Cheryl A Sadowski
Journal:  Can Pharm J (Ott)       Date:  2017-07-12

7.  Estimates and determinants of HPV non-vaccination and vaccine refusal in girls 12 to 14 y of age in Canada: Results from the Childhood National Immunization Coverage Survey, 2013.

Authors:  Nicolas L Gilbert; Heather Gilmour; Ève Dubé; Sarah E Wilson; Julie Laroche
Journal:  Hum Vaccin Immunother       Date:  2016-03-04       Impact factor: 3.452

8.  Investigating Canadian parents' HPV vaccine knowledge, attitudes and behaviour: a study protocol for a longitudinal national online survey.

Authors:  Gilla K Shapiro; Samara Perez; Anila Naz; Ovidiu Tatar; Juliet R Guichon; Rhonda Amsel; Gregory D Zimet; Zeev Rosberger
Journal:  BMJ Open       Date:  2017-10-11       Impact factor: 2.692

9.  Comparing human papillomavirus vaccine concerns on Twitter: a cross-sectional study of users in Australia, Canada and the UK.

Authors:  Gilla K Shapiro; Didi Surian; Adam G Dunn; Ryan Perry; Margaret Kelaher
Journal:  BMJ Open       Date:  2017-10-05       Impact factor: 2.692

Review 10.  Human Papillomavirus Vaccination Uptake in Canada: A Systematic Review and Meta-analysis.

Authors:  Yelena Bird; Olatunji Obidiya; Razi Mahmood; Chijioke Nwankwo; John Moraros
Journal:  Int J Prev Med       Date:  2017-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.